日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial

marstacimab预防治疗A/B型血友病伴抑制剂的疗效和安全性:来自3期BASIS试验的结果

Matino, Davide; Acharya, Suchitra S; Taylor, Carrie Turich; Sun, Pengling; Agathon, Delphine; Raje, Sangeeta; Gould, Travis; Palladino, Andrew; Mahlangu, Johnny; Lissitchkov, Toshko; Todorova, Mariya; Chan, Anthony; Carcao, Manuel; Sun, Jing; Yang, Renchi; Wu, Runhui; Jin, Chenghao; Zeng, Xiaojing; Boban, Ana; Bilic, Ernest; Frenzel, Laurent; Fung Chan, Godfrey Chi; Kong Li, Chi; Apte, Shashikant; Choraria, Nirmalkumar; Chistolini, Antonio; Marchesini, Emanuela; Peyvandi, Flora; Fujii, Teruhisa; Matsushita, Tadashi; Kaneda, Makoto; Lyu, Chuhl Joo; Park, Young Shil; Kim, SungEun; Martinez, Laura Villarreal; Adrian, Javier Morales; Wali, Yasser; Al Khabori, Murtadha; Kurtov, Igor; Alzahrani, Hazzaa; Zaher, Galila; Micic, Dragan; Miljic, Predrag; Kostic, Gordana; Vucic, Miodrag; Djurdjevic, Predrag; Hidalgo, Olga Benitez; Porras, Jose Gonzalez; Jiménez-Yuste, Víctor; Calvo Villas, Jose Manuel; Lopez Fernandez, Maria Fernanda; Albayrak, Canan; Okan, Vahap; Balkan, Can; Sahin, Fahri; Antmen, Ali; Unal, Ekrem; Visweshwar, Nathan; Sharathkumar, Anjali; Kruse-Jarres, Rebecca

Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis

血浆来源的血管性血友病因子/因子VIII浓缩物(Wilate)预防治疗在3型血管性血友病患者中的疗效和安全性——WIL-31研究亚组分析

Djambas Khayat, Claudia; Dubey, Leonid; Inati, Adlette; Lissitchkov, Toshko; Novik, Dzmitry; Peteva, Elina; Sidonio, Robert F Jr; Taher, Ali T; Vilchevska, Kateryna V; Vdovin, Vladimir; Boban, Ana

Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B

菲图西兰预防性治疗及围手术期管理在A型或B型血友病患者中的长期安全性和有效性

Pipe, Steven W; Lissitchkov, Toshko; Georgiev, Pencho; Mangles, Sarah; Hegemann, Inga; Trinchero, Alice; Chowdary, Pratima; Forbes, Adam; Feng, Liqi; Menapace, Laurel A; Kichou, Salim; Andersson, Shauna; Demissie, Marek; Ragni, Margaret V

Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease-a WIL-31 subanalysis

个体化给药频率可能提高血管性血友病患者的预防效果——一项WIL-31亚组分析

Sidonio, Robert F Jr; Boban, Ana; Lissitchkov, Toshko; Nemes, Laszlo; Vdovin, Vladimir; Khayat, Claudia Djambas

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease

儿童和成人血管性血友病患者的血管性血友病因子/因子VIII浓缩物(Wilate)预防

Sidonio, Robert F Jr; Boban, Ana; Dubey, Leonid; Inati, Adlette; Kiss, Csongor; Boda, Zoltan; Lissitchkov, Toshko; Nemes, Laszlo; Novik, Dzmitry; Peteva, Elina; Taher, Ali T; Timofeeva, Margarita Arkadevna; Vilchevska, Kateryna V; Vdovin, Vladimir; Werner, Sylvia; Knaub, Sigurd; Djambas Khayat, Claudia

Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa

重组因子 VIII 在成人严重血友病 A 中的药代动力学:octocog alfa、rurioctocog alfa pegol 和 efanesoctocog alfa 的固定序列单剂量研究

Lissitchkov, Toshko; Willemze, Annemieke; Jan, Christelle; Zilberstein, Moshe; Katragadda, Suresh

Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients

在B型血友病患者中,每21天进行一次延长半衰期的IX因子预防性治疗:一项针对特定成年患者的疗效和安全性纵向分析

Pabinger, Ingrid; Lissitchkov, Toshko; Nagao, Asuza; Lepatan, Lynda Mae; Li, Yanyan; Seifert, Wilfried; Mancuso, Maria Elisa

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

成人免疫性血小板减少症中使用血小板生成素受体激动剂:系统评价和中欧专家共识

Pulanić, Dražen; Bátorová, Angelika; Bodó, Imre; Červinek, Libor; Ionita, Ioana; Lissitchkov, Toshko; Melikyan, Anahit; Podolak-Dawidziak, Maria

Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study

依凡西妥昔单抗治疗A型血友病:一项1期重复给药研究的结果

Lissitchkov, Toshko; Willemze, Annemieke; Katragadda, Suresh; Rice, Kara; Poloskey, Stacey; Benson, Craig

Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A

专家对当前和未来旨在提高A型血友病患者保护水平的预防性疗法的意见

Batorova, Angelika; Boban, Ana; Brinza, Melen; Lissitchkov, Toshiko; Nemes, Laszlo; Zupan Preložnik, Irena; Smejkal, Petr; Zozulya, Nadezhda; Windyga, Jerzy